Metastatic Castration Sensitive Prostate Cancer (mCSPC) trials recruiting in North Carolina

Fewer than 3 recruiting trials found.

All Metastatic Castration Sensitive Prostate Cancer (mCSPC) trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
  NCT07028853 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · North Carolina: Cary, Durham, Raleigh